| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.6M | +99.1% |
| R&D Expense | $13.5M | +29.3% |
| SG&A Expense | $4.2M | -43.3% |
| Operating Income | -$11.1M | +23.7% |
| Pre-tax Income | -$10.7M | +23.9% |
| Income Tax | $50K | +1259.3% |
| Net Income | -$10.7M | -30.3% |
| EPS (Basic) | -$1.19 | -26.6% |
| EPS (Diluted) | -$1.19 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19.2M | +27.0% |
| Current Assets | $22.0M | +28.6% |
| Total Assets | $22.0M | +28.6% |
| Current Liabilities | $3.5M | +12.7% |
| Total Liabilities | $3.5M | +12.7% |
| Stockholders' Equity | $18.6M | +32.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.9M | +33.6% |
| Investing Cash Flow | $18.7M | +0.0% |
| Financing Cash Flow | $15.0M | +1256.5% |
| -26.6% |